期刊文献+

一种新的肿瘤标志物HE4在妇科盆腔恶性肿瘤诊断中的应用 被引量:4

原文传递
导出
摘要 目前肿瘤癌原125(CA125)检测被广泛应用于临床卵巢癌的诊断,但由于子宫内膜异位症、盆腔炎症等也会导致CA125升高,因此,需要一种敏感性和特异性较强的标志物来提高卵巢癌的诊断水平。人附睾蛋白4(human epididymis protein 4,HFA)基因最早是从人附睾上皮细胞中发现,1991年被成功克隆,1999年Schummer等和Wang等通过cDNA微阵列分析才发现HE4基因与卵巢癌有关,
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2009年第1期93-94,共2页 Chinese Journal of Microbiology and Immunology
基金 基金项目:河北省科技厅科技研究与发展指导计划课题(072761638)
  • 相关文献

参考文献5

  • 1Schummer M, Ng WV, Bumgarner RE, et al. Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas. Gene, 1999, 238 ( 2 ) : 375-385.
  • 2Wang K, Gan L, Jeffery E, et al. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray. Gene, 1999, 229(1-2) : 101-108.
  • 3Hellstrom I, Raycraft J, Hayden-Ledbetter M, et al. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res, 2003, 63(13): 3695-3700.
  • 4Ozols R, Rubin S, Thomas G, et al. Epithelial ovarian cancer. Philadelphia: Lippincott Williams and Wilkins, 2000.
  • 5Menon U, Jacobs I. Ovarian cancer screening in the general population. Ultrasound Obstet Gynecol, 2000, 15 (5) : 350-353.

同被引文献42

  • 1白香玲.CA125、AFP、CEA联合检测在卵巢癌诊断中的应用[J].青海医药杂志,2007,37(5):60-61. 被引量:8
  • 2单景庆.抑癌基因PTEN与子宫内膜癌的研究进展[J].现代肿瘤医学,2006,14(7):900-901. 被引量:4
  • 3Colombo N,Van Gorp T,Parma G,et al.Ovarian cancer[J].Crit Rev Oncol Hematol,2006,60(2):159-179.
  • 4Bast RC Jr,Badgwell D,Lu Z,et al.New tumor markers:CA125 and beyond[J].Int J Gynecol Cancer,2005,15 (3):274-281.
  • 5Lowe KA,Shah C,Wallace E,et al.Effects of personal characteristics on serum CA125,mesothelin,and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer[J].Cancer Epidemiol Biomarkers Prev,2008,17(9):2480-2487.
  • 6Moore RG,Brown AK,Miller MC,et al.The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass[J].Gynecol Oncol,2008,108(2):402-408.
  • 7Purdie DM, Green AC. Epidemiology of endometrial cancer[ J ]. Best Pract Res Clin Obstet Gynaecol, 2001, 15(3) : 341 -354.
  • 8Kohorn EI. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment [J]. IntJGynecolCancer, 2001, 11(1):73-77.
  • 9Drapkin R, von Horsten HH, Lin Y, et al. Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas [ J ]. Cancer Res, 2005, 65 (6) : 2162 -2169.
  • 10Galgano MT, Hampton GM, Frierson HF Jr. Comprehensive analysis of HE4 expression in normal and malignant human tissues [ J ]. Mod Pathol, 2006, 19(6) : 847 -853.

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部